Symrise AG has announced a public cash offer to the shareholders of Probi AB (publ) (“Probi”). The offer values Probi at approximately SEK 3,988 million. The shares in Probi are traded on Nasdaq Stockholm, Mid Cap.
Probi is a global biotics solutions company, focused on researching, manufacturing, and delivering biotics for supplements and functional food.
Vinge’s team mainly consists of Jesper Schönbeck, Erik Sjöman, Linnéa Sellström, Benjamin Vafaeian and Hannah Mark (Capital Markets and Public M&A) and Daniel Wendelsson and Noelia Martinez (FDI).
